SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
STEM Analysis & Videos »
STEM: Bull or Bear?
New Stock Indexes to Track Trends in Healthcare Sector
STEM
|
|
|
-19.72%
in
13 days
Coming Soon. . . a premium service offered in collaboration with Investars YOU for full access to a global database of over 1,000 stocks which are organized and managed within my 20 ProActive HavRx stock indexes . The expected pricing for premium access is $60 per year and will include full access to all of the component stocks in the indexes and tracking data for the indexes. <> Emerging Cancer Diagnostic / Therapeutic (Dx / Tx) Index
The actively managed HavRx Emerging Cancer Dx / Tx Index constituents reflect a cross-section of emerging cancer companies with <><><><><><><><><><><><><><><><><><><>< />< /><><>< />< /><><>< />< />< />< /><><>< />< /><><>< />< /><><>< />< /><><><><><><><><><><>< />< /><><>< />< />< />< /><><>< />< /><><>< />< /><><>< />< />< />< /><><>< />< />< />< /><><>< />< />< />< /><><>< />< /><><><><><><><><><>...
|
Bullish on STEM ...
STEM
|
|
|
+0.00%
in
4 minutes
(closed on 10/20/09)
Stem cell transplants stalled blindness in rats ...The findings raise hope for use of the treatment in humans with a range of diseases in which the retina become damaged, including age-related macular degeneration or AMD, which affects nearly 30 million people worldwide, including 15 million Americans... http://www.reuters.com/article/companyNews/idUKTRE59I6G120091...
|
Stem Cell Index Surges in Past Week
STEM
|
|
|
-16.47%
in
171 days
(closed on 10/28/09)
<> The stem cell trade was back in a big way over the past week, with several stocks in the <font> ETF Innovators Stem Cell Index </font> registering impressive gains, compared to market and biotech ETF benchmarks such as the S&P 500 SPDR (NYSE:SPY) +6%, iShares Nasdaq Biotech (NASDAQ:IBB) +2%, SPDR S&P Biotech (NYSE:XBI +4%). Hot stocks over the past week among the 40 component companies in the stem cell index include NeoStem (AMEX:NBS) +52.2%, Cytori Therapeutics (NASDAQ:CYTX) +37%, and Geron (NASDAQ:GERN) +22%. Two other widely followed stocks from the index registered smaller gains,...
|
Stem Cell Index: YTD Analysis, Banking on NeoStem
STEM
|
|
|
+5.59%
in
29 days
(closed on 05/10/09)
<> <> <> <!-- <td valign="top" width="1%"> <img src="/images/quotes.gif" /> </td> --> <> <> Related Tickers: NBS, IART, OSIR, STEM, GE, XLV, IBB, XBI, PBE, SPY Disclosure: No Positions <> The ETF Innovators Global Stem Cell and Regenerative Medicine Index tracks the performance of 40 stem cell and regenerative medicine companies on a globa...
|
Analysis of Global Stem Cell Index YTD
STEM
|
|
|
+45.93%
in
6 days
(closed on 03/10/09)
The accompanying table includes statistics for the 40 companies in the ETF Innovators Global Stem Cell and Regenerative Medicine Index , which is down 13.8% at a value of 3,387 from a 2/22/09 inception date value of 3,928. The index is down 30.6% over the past year on an equal-weight basis, compared to losses of 31.2% for the Healthcare Sector SPDR (XLV), 19% for iShares Nasdaq Biotech (IBB), 14.7% for SPDR S&P Biotech (XBI), 29.7% for PowerShares Biotech & Genome (PBE), and 46.1% for the S&P 500 SPDR (SPY). <> Below is a profile for each company, including a summary of their b...
|
Global Stem Cell and Regenerative Medicine Index
STEM
|
|
|
-27.81%
in
7 days
(closed on 03/04/09)
By Mike Havrilla on 2/25/09
www.BioMedReports.com The ETF Innovators Global Stem Cell and Regenerative Medicine Index includes 40 companies with market caps less than $1B at the index inception and the total market value of the index will be tracked as a gauge of investor and trader sentiment toward stem cell companies from a starting value of 3,928 on 2/22/09 and current value of 3,860 as of 2/25/09 - down 1.7% from the closing value last week. <> <> The index is down 23.8% over the past year on an equal-weight basis, compared to losses of 21.4% for the Heal...
|
Global Stem Cell Index Down 9% Last Week
STEM
|
|
|
-4.59%
in
3 days
(closed on 02/25/09)
Global Stem Cell Index Down 9% Last Week By Mike Havrilla on 2/21/09 The ETF Innovators Global Stem Cell and Regenerative Medicine Index of 40 companies with market caps less than $1B at the index inception lost 9% of its value last week and is down 24.8% over the past year on an equal-weight basis, compared to losses of 21.6% for the Healthcare Sector SPDR (XLV), 8.4% for iShares Nasdaq Biotech (IBB), 4.5% for SPDR S&P Biotech (XBI), 19.9% for PowerShares Biotech & Genome (PBE), and 41.6% for the S&P 500 SPDR (SPY).
|
Global Stem Cell and Regenerative Medicine Index
STEM
|
|
|
-19.01%
in
4 days
(closed on 02/22/09)
Global Stem Cell and Regenerative Medicine Index By Mike Havrilla on 2/17/09 <> The table at my website link below includes 40 companies in the ETF Innovators Global Stem Cell and Regenerative Medicine Index, which represents an expansion of the Emerging Stem Cell Index I have written about previously . The expanded global index includes companies with market caps less than $1B at the index inception with a total market value of $3,814 as of the close today. As previously, I will track the total market value for a more comprehensive gauge of investor sentiment...
|
New Website for Healthcare Investors and Traders
STEM
|
|
|
-8.20%
in
6 days
(closed on 02/16/09)
<> A new website for healthcare investors and traders should be ready to launch by the end of February, which is designed to provide users with more features beyond my current blog format.
The site will feature its own blog, discussion forum, news feeds, videos, stock commentaries (including multiple contributors), and other unique content – including my FDA and Clinical Trial Calendars plus a database that includes hundreds of foreign and U.S.-listed stocks in the healthcare sector which are organized into unique indexes, including:
1....
|
Healthcare Investing Trends in '09 and Beyond
STEM
|
|
|
-5.43%
in
3 days
(closed on 02/10/09)
<> While the departure of Tom Daschle and concerns over rising unemployment and the global economic slowdown may hamper many of President Obama's plans for healthcare reform; there are several growth trends within the sector outlined below which are poised to benefit in 2009 and beyond. Follow any of the links below for more information on the new ETF Innovators indexes and exchange-traded fund ideas for the sector.
Global Health IT : The top five rated companies include Swiss telemedicine firm Card Guard (CDGUF) – a pro< />< />< />< /><>< />< />< />< /><><>< />< /><>< />< />< />< /><>...
|
An Expanded Emerging Stem Cell Index
STEM
|
|
|
+7.50%
in
3 days
(closed on 02/07/09)
An Expanded Emerging Stem Cell Index By Mike Havrilla on 2/3/09 ETF Innovators The table at my website link below includes 32 companies in the ETF Innovators Emerging Stem Cell Index of U.S.-listed stocks with market caps below $250M. I will maintain the index with these 32 components and track the total market value and stock price changes as an indicator of investor and trader sentiment toward the stem cell and regenerative medicine space. <> Below is a list of a...
|
New Emerging Stem Cell Index
STEM
|
|
|
-4.00%
in
2 days
(closed on 02/04/09)
New Emerging Stem Cell Index Shares of Geron (GERN) and other well known stem cell and regenerative medicine stocks such as Osiris Therapeutics (OSIR) and StemCells (STEM) have been soaring since the FDA allowed human clinical testing for Geron's embryonic stem cell treatment candidate for spinal cord injuries. <> The table at my website link below highlights 25 U.S.-listed stem cell and regenerative medicine companies with market caps of below $200M which are included in the ETF Innovators Emerging Stem Cell Index. The companies are also listed below in descending ...
|
Healthcare Hot Spots Beyond Stem Cells
STEM
|
|
|
-15.25%
in
7 days
(closed on 02/02/09)
Beyond Stem Cells: Healthcare Hot Spots With the surprise announcement last week by Geron (GERN) that the FDA would allow human clinical trials for embryonic stem cells, all companies in the underlying ETF Innovators Index to track the space are screaming higher again today – led by the company with the biggest gains over the past year, StemCells (STEM). <> Below are three additional areas and associated companies for investors to consider in the search of the next hot s...
|
People Bullish on STEM
People Bearish on STEM
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on STEM |
|
|
|
|
sam1933
(-5.78% risk: conservative)
|
|
|
EMGE-Stem Cell Play
- I think the significance of this Press Release has been overlooked, and hope the company has more plans to explain its story:
Emergent Health Corp. (E...
|
More Resources
|
STEM
About StemCells Inc.
- Answers.com
